Item 8.01 Other Events.
On February 21, 2013, Cumberland Pharmaceuticals Inc. issued a press release
announcing that it has entered into an exclusive agreement with Sandor Medicaids
Pvt. Ltd., an India-based pharmaceutical company, for the commercialization of
Caldolor® (ibuprofen) Injection in India. A copy of the press release is
attached as Exhibit 99.1.